- Library Home /
- Search Collections /
- Open Collections /
- Browse Collections /
- UBC Theses and Dissertations /
- Evolutionarily conserved synthetic lethal interaction...
Open Collections
UBC Theses and Dissertations
UBC Theses and Dissertations
Evolutionarily conserved synthetic lethal interaction networks reveal targets for anticancer therapeutic development van Pel, Derek Michael
Abstract
Cancer is a multigenic disease. The genetic distinctness of cancer cells offers a weakness that can be exploited: for example, nearly all cancers carry mutations in processes relating to the maintenance of genomic stability. As this is an essential process, this presents a weakness that can be leveraged towards inviability – a concept known as synthetic lethality. The ideal cancer therapeutic would have a broad spectrum, but genetic techniques in human cells are not sufficiently developed to identify the spectrum of synthetic lethal interactions of sets of genome stability genes easily. The use of model organisms can facilitate the identification of second-site targets for the development of anticancer therapeutics, and allows the construction of synthetic lethal interaction networks. This has the potential to identify “hub” genes having synthetic lethal interactions with many cancermutated orthologs. If these synthetic lethal interactions are found to be conserved in human cells, these highly connected hub genes are potential targets for therapeutic development. Assembly of a synthetic lethal interaction network of yeast orthologs of 10 genes mutated in colorectal cancer, based on data in Saccharomyces cerevisiae, previously identified five such synthetic lethal hub genes in yeast. In this thesis, the evolutionary conservation of this network is interrogated in mammalian cells. The interactions between orthologs of colorectal cancer CIN genes in yeast were found to be highly conserved in human cells. A highthroughput assay to screen for small-molecule inhibitors of the protein encoded by one such gene, FEN1, was developed and used to identify 13 compounds that inhibited FEN1 in vitro with IC50 values in the low-micromolar range or less. These compounds were applied to cells bearing mutation in the tumor suppressor CDC4, and two compounds were found to yield selective killing of CDC4-deficient cells. Finally, yeast genetic techniques were used to characterize CTF4, a second highly connected hub gene within the colon cancer CIN gene network, and to expand the therapeutic range of cancers that could be selectively killed by inhibitors of Ctf4/WDHD1 or Rad27/FEN1. Taken together, these data demonstrate the considerable power of applying model organisms genetics to the discovery of new anticancer therapeutic targets.
Item Metadata
Title |
Evolutionarily conserved synthetic lethal interaction networks reveal targets for anticancer therapeutic development
|
Creator | |
Publisher |
University of British Columbia
|
Date Issued |
2012
|
Description |
Cancer is a multigenic disease. The genetic distinctness of cancer cells offers a
weakness that can be exploited: for example, nearly all cancers carry mutations in processes
relating to the maintenance of genomic stability. As this is an essential process, this presents
a weakness that can be leveraged towards inviability – a concept known as synthetic
lethality. The ideal cancer therapeutic would have a broad spectrum, but genetic techniques
in human cells are not sufficiently developed to identify the spectrum of synthetic lethal
interactions of sets of genome stability genes easily. The use of model organisms can
facilitate the identification of second-site targets for the development of anticancer
therapeutics, and allows the construction of synthetic lethal interaction networks. This has the
potential to identify “hub” genes having synthetic lethal interactions with many cancermutated
orthologs. If these synthetic lethal interactions are found to be conserved in human
cells, these highly connected hub genes are potential targets for therapeutic development.
Assembly of a synthetic lethal interaction network of yeast orthologs of 10 genes mutated in
colorectal cancer, based on data in Saccharomyces cerevisiae, previously identified five such
synthetic lethal hub genes in yeast. In this thesis, the evolutionary conservation of this
network is interrogated in mammalian cells. The interactions between orthologs of colorectal
cancer CIN genes in yeast were found to be highly conserved in human cells. A highthroughput
assay to screen for small-molecule inhibitors of the protein encoded by one such
gene, FEN1, was developed and used to identify 13 compounds that inhibited FEN1 in vitro
with IC50 values in the low-micromolar range or less. These compounds were applied to cells
bearing mutation in the tumor suppressor CDC4, and two compounds were found to yield
selective killing of CDC4-deficient cells. Finally, yeast genetic techniques were used to characterize CTF4, a second highly connected hub gene within the colon cancer CIN gene
network, and to expand the therapeutic range of cancers that could be selectively killed by
inhibitors of Ctf4/WDHD1 or Rad27/FEN1. Taken together, these data demonstrate the
considerable power of applying model organisms genetics to the discovery of new anticancer
therapeutic targets.
|
Genre | |
Type | |
Language |
eng
|
Date Available |
2013-04-30
|
Provider |
Vancouver : University of British Columbia Library
|
Rights |
Attribution 3.0 Unported
|
DOI |
10.14288/1.0073341
|
URI | |
Degree | |
Program | |
Affiliation | |
Degree Grantor |
University of British Columbia
|
Graduation Date |
2012-11
|
Campus | |
Scholarly Level |
Graduate
|
Rights URI | |
Aggregated Source Repository |
DSpace
|
Item Media
Item Citations and Data
Rights
Attribution 3.0 Unported